Key result
VA-ECMO supports complete cardiac recovery after 10 days in H1N1 fulminant myocarditis and cardiogenic shock.
Why the study?
Does an extra-corporal membrane oxygenator successfully treat fulminant myocarditis associated with 2009 pH1N1 influenza virus?
Case Report (n=1)
No
Does an extra-corporal membrane oxygenator successfully treat fulminant myocarditis associated with 2009 pH1N1 influenza virus?
Extracorporeal membrane oxygenation can be a successful treatment strategy for fulminant myocarditis associated with the 2009 pH1N1 influenza virus.
Answers are grounded in this paper and cite their sources.
Supports VA-ECMO feasibility in select viral fulminant myocarditis; leaves open need for prospective validation.
The prevalence of myocardial involvement in influenza infection ranges from 0% to 12%. The 2009 pH1N1 influenza virus, formerly known as swine flu, first appeared in Mexico and the United States of America in March and April 2009 and has swept the globe with unprecedented speed. We report a case of fulminant myocarditis associated with this virus treated successfully using extra-corporal membrane oxygenator.
No takes yet. Share an insight, caveat, or question.
Mohite et al. (2011) conducted a case report in Fulminant myocarditis associated with H1N1 influenza (n=1). Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO) was evaluated on Survival and cardiac recovery. Veno-arterial extracorporeal membrane oxygenation successfully supported an 18-year-old female with H1N1 influenza-related fulminant myocarditis and cardiogenic shock, leading to complete cardiac recovery after 10 days.
Synapse has enriched 10 related papers. Consider them for comparative context: